801 related articles for article (PubMed ID: 19644505)
21. Low-dose oral sildenafil for patients with pulmonary hypertension: a cost-effective solution in countries with limited resources.
Vida VL; Gaitan G; Quezada E; Barnoya J; Castañeda AR
Cardiol Young; 2007 Feb; 17(1):72-7. PubMed ID: 17184573
[TBL] [Abstract][Full Text] [Related]
22. Sildenafil improves exercise capacity and quality of life in patients with systolic heart failure and secondary pulmonary hypertension.
Lewis GD; Shah R; Shahzad K; Camuso JM; Pappagianopoulos PP; Hung J; Tawakol A; Gerszten RE; Systrom DM; Bloch KD; Semigran MJ
Circulation; 2007 Oct; 116(14):1555-62. PubMed ID: 17785618
[TBL] [Abstract][Full Text] [Related]
23. The efficacy and tolerability of sildenafil in patients with moderate-to-severe pulmonary hypertension.
Bharani A; Mathew V; Sahu A; Lunia B
Indian Heart J; 2003; 55(1):55-9. PubMed ID: 12760589
[TBL] [Abstract][Full Text] [Related]
24. One year efficacy and safety of oral sildenafil treatment in severe pulmonary hypertension.
Samarzija M; Zuljević E; Jakopović M; Sever B; Knezević A; Dumija Z; Vidjak V; Samija M
Coll Antropol; 2009 Sep; 33(3):799-803. PubMed ID: 19860106
[TBL] [Abstract][Full Text] [Related]
25. Beneficial effect of oral sildenafil therapy on childhood pulmonary arterial hypertension: twelve-month clinical trial of a single-drug, open-label, pilot study.
Humpl T; Reyes JT; Holtby H; Stephens D; Adatia I
Circulation; 2005 Jun; 111(24):3274-80. PubMed ID: 15956137
[TBL] [Abstract][Full Text] [Related]
26. Vardenafil treatment for patients with pulmonary arterial hypertension: a multicentre, open-label study.
Jing ZC; Jiang X; Wu BX; Xu XQ; Wu Y; Ma CR; Wang Y; Yang YJ; Pu JL; Gao W
Heart; 2009 Sep; 95(18):1531-6. PubMed ID: 19549620
[TBL] [Abstract][Full Text] [Related]
27. Sildenafil for pulmonary hypertension secondary to congenital heart diseases.
Gupta A; Kerkar P
Indian Heart J; 2007; 59(4):342-5. PubMed ID: 19126940
[TBL] [Abstract][Full Text] [Related]
28. Sildenafil improves exercise hemodynamics and oxygen uptake in patients with systolic heart failure.
Lewis GD; Lachmann J; Camuso J; Lepore JJ; Shin J; Martinovic ME; Systrom DM; Bloch KD; Semigran MJ
Circulation; 2007 Jan; 115(1):59-66. PubMed ID: 17179022
[TBL] [Abstract][Full Text] [Related]
29. Immediate and long-term hemodynamic and clinical effects of sildenafil in patients with pulmonary arterial hypertension receiving vasodilator therapy.
Bhatia S; Frantz RP; Severson CJ; Durst LA; McGoon MD
Mayo Clin Proc; 2003 Oct; 78(10):1207-13. PubMed ID: 14531479
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and safety of sildenafil added to treprostinil in pulmonary hypertension.
Gomberg-Maitland M; McLaughlin V; Gulati M; Rich S
Am J Cardiol; 2005 Nov; 96(9):1334-6. PubMed ID: 16253609
[TBL] [Abstract][Full Text] [Related]
31. Effectiveness and safety of treatment with sildenafil for secondary pulmonary hypertension in heart transplant candidates.
Zakliczynski M; Maruszewski M; Pyka L; Trybunia D; Nadziakiewicz P; Przybylski R; Zembala M
Transplant Proc; 2007 Nov; 39(9):2856-8. PubMed ID: 18022001
[TBL] [Abstract][Full Text] [Related]
32. Comparative efficacy of sildenafil in Eisenmenger's syndrome secondary to atrial septal defect versus ventricular septal defect: a cardiac catheterisation follow-up study.
Garg N; Tripathy N; Sinha N
Cardiol Young; 2011 Dec; 21(6):631-8. PubMed ID: 21729508
[TBL] [Abstract][Full Text] [Related]
33. Pulmonary hypertension in end-stage pulmonary sarcoidosis: therapeutic effect of sildenafil?
Milman N; Burton CM; Iversen M; Videbaek R; Jensen CV; Carlsen J
J Heart Lung Transplant; 2008 Mar; 27(3):329-34. PubMed ID: 18342757
[TBL] [Abstract][Full Text] [Related]
34. Bosentan-sildenafil association in patients with congenital heart disease-related pulmonary arterial hypertension and Eisenmenger physiology.
D'Alto M; Romeo E; Argiento P; Sarubbi B; Santoro G; Grimaldi N; Correra A; Scognamiglio G; Russo MG; Calabrò R
Int J Cardiol; 2012 Mar; 155(3):378-82. PubMed ID: 21081251
[TBL] [Abstract][Full Text] [Related]
35. Use of sildenafil in heart transplant recipients with pulmonary hypertension may prevent right heart failure.
Maruszewski M; Zakliczyński M; Przybylski R; Kucewicz-Czech E; Zembala M
Transplant Proc; 2007 Nov; 39(9):2850-2. PubMed ID: 18021999
[TBL] [Abstract][Full Text] [Related]
36. Sildenafil for primary and secondary pulmonary hypertension.
Watanabe H; Ohashi K; Takeuchi K; Yamashita K; Yokoyama T; Tran QK; Satoh H; Terada H; Ohashi H; Hayashi H
Clin Pharmacol Ther; 2002 May; 71(5):398-402. PubMed ID: 12011826
[TBL] [Abstract][Full Text] [Related]
37. A study of clinical efficacy of sildenafil in patients with primary pulmonary hypertension.
Sastry BK; Narasimhan C; Reddy NK; Anand B; Prakash GS; Raju PR; Kumar DN
Indian Heart J; 2002; 54(4):410-4. PubMed ID: 12462670
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetic and hemodynamic responses to oral sildenafil during invasive testing in children with pulmonary hypertension.
Apitz C; Reyes JT; Holtby H; Humpl T; Redington AN
J Am Coll Cardiol; 2010 Apr; 55(14):1456-62. PubMed ID: 20359596
[TBL] [Abstract][Full Text] [Related]
39. Effects of chronic sildenafil in patients with Eisenmenger syndrome versus idiopathic pulmonary arterial hypertension.
Chau EM; Fan KY; Chow WH
Int J Cardiol; 2007 Sep; 120(3):301-5. PubMed ID: 17174418
[TBL] [Abstract][Full Text] [Related]
40. Long-term outcome of systemic sclerosis-associated pulmonary arterial hypertension treated with bosentan as first-line monotherapy followed or not by the addition of prostanoids or sildenafil.
Launay D; Sitbon O; Le Pavec J; Savale L; Tchérakian C; Yaïci A; Achouh L; Parent F; Jais X; Simonneau G; Humbert M
Rheumatology (Oxford); 2010 Mar; 49(3):490-500. PubMed ID: 20015974
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
